{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T10:50:08Z","timestamp":1783335008852,"version":"3.54.6"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T00:00:00Z","timestamp":1693094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T00:00:00Z","timestamp":1693094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The purpose of this study is to evaluate the efficacy of prophylactic use amphotericin B in patients with hematologic disorders complicated by neutropenia. We searched the PubMed, EMBASE, The Cochrane Library, CBM, CNKI, VIP and WanFang Data database and the China Clinical Trials Registry (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\">www.chictr.org.cn<\/jats:ext-link>) to collect randomized controlled trials (RCTs) of amphotericin B for patients with hematologic disorders complicated by neutropenia from inception to May 2023. The Cochrane risk-of-bias tool for RCTs was used to assess the bias risk of the included studies. The meta-analysis was performed using RevMan 5.3 software. A total of 6 studies with a total of 1019 patients were included. The results of the meta-analysis showed that the treatment group was superior to the control group in terms of the fungal infection rate, and the differences were statistically significant [RR\u2009=\u20090.47, 95% CI (0.32, 0.69), <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001]. There was no significant difference between the two groups in terms of the mortality [RR\u2009=\u20090.87, 95% CI (0.61, 1.23), <jats:italic>P<\/jats:italic>\u2009=\u20090.43] and the incidence of colonization [OR\u2009=\u20090.51, 95% CI (0.25, 1.03), <jats:italic>P<\/jats:italic>\u2009=\u20090.06]. The evidence shows that amphotericin B prophylactic use for patients with hematologic disorders complicated by neutropenia can decrease the fungal infection rate. However, there was no significant difference in reducing mortality or the incidence of colonization. Due to the limited quality and quantity of the included studies, more high-quality studies are needed to verify the above conclusion.<\/jats:p>","DOI":"10.1038\/s41598-023-41268-1","type":"journal-article","created":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T13:02:14Z","timestamp":1693141334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prophylactic use amphotericin B use in patients with hematologic disorders complicated by neutropenia: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"13","author":[{"given":"Zhaoyan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,27]]},"reference":[{"issue":"2","key":"41268_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.blre.2016.09.002","volume":"31","author":"L Pagano","year":"2017","unstructured":"Pagano, L. et al. Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations. Blood Rev. 31(2), 17\u201329 (2017).","journal-title":"Blood Rev."},{"issue":"3","key":"41268_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jinf.2010.06.018","volume":"61","author":"T Lehrnbecher","year":"2010","unstructured":"Lehrnbecher, T. et al. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J. Infect. 61(3), 259\u2013265 (2010).","journal-title":"J. Infect."},{"issue":"2","key":"41268_CR3","doi-asserted-by":"publisher","first-page":"E18","DOI":"10.1177\/014556131709600214","volume":"96","author":"M Hasibi","year":"2017","unstructured":"Hasibi, M. et al. Efficacy of Intralipid infusion in reducing amphotericin-B-associated nephrotoxicity in head and neck invasive fungal infection: A randomized, controlled trial. Ear Nose Throat J. 96(2), E18\u2013E22 (2017).","journal-title":"Ear Nose Throat J."},{"issue":"4","key":"41268_CR4","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1158\/1541-7786.MCR-19-0768","volume":"18","author":"KCS Oliveira","year":"2020","unstructured":"Oliveira, K. C. S. et al. Current perspectives on circulating tumor DNA, precision medicine, and personalized clinical management of cancer. Mol. Cancer Res. 18(4), 517\u2013528 (2020).","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"41268_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/tid.12324","volume":"17","author":"SM Trifilio","year":"2015","unstructured":"Trifilio, S. M. et al. Amphotericin B deoxycholate nasal spray administered to hematopoietic stem cell recipients with prior fungal colonization of the upper airway passages is associated with low rates of invasive fungal infection. Transpl. Infect. Dis. 17(1), 1\u20136. https:\/\/doi.org\/10.1111\/tid.12324 (2015) (Epub 2015 Jan 14 PMID: 25620386).","journal-title":"Transpl. Infect. Dis."},{"issue":"9","key":"41268_CR6","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1086\/586739","volume":"46","author":"BJ Rijnders","year":"2008","unstructured":"Rijnders, B. J. et al. Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: A randomized, placebo-controlled trial. Clin. Infect. Dis. 46(9), 1401\u20131408 (2008).","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"41268_CR7","first-page":"3654","volume":"93","author":"S Schwartz","year":"1999","unstructured":"Schwartz, S. et al. Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: Results of a prospective randomized multicenter trial. Blood 93(11), 3654\u20133661 (1999).","journal-title":"Blood"},{"issue":"6","key":"41268_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/BF01697981","volume":"71","author":"GF Behre","year":"1995","unstructured":"Behre, G. F. et al. Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients. Ann. Hematol. 71(6), 287\u2013291 (1995).","journal-title":"Ann. Hematol."},{"issue":"6","key":"41268_CR9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0002-9343(94)90345-X","volume":"97","author":"DK Riley","year":"1994","unstructured":"Riley, D. K. et al. The prophylactic use of low-dose amphotericin B in bone marrow transplant patients. Am. J. Med. 97(6), 509\u2013514 (1994).","journal-title":"Am. J. Med."},{"issue":"5","key":"41268_CR10","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/infdis\/165.5.891","volume":"165","author":"JR Perfect","year":"1992","unstructured":"Perfect, J. R. et al. Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients. J. Infect. Dis. 165(5), 891\u2013897 (1992).","journal-title":"J. Infect. Dis."},{"issue":"1","key":"41268_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0002-9343(82)90594-0","volume":"72","author":"PA Pizzo","year":"1982","unstructured":"Pizzo, P. A. et al. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am. J. Med. 72(1), 101\u2013111 (1982).","journal-title":"Am. J. Med."},{"issue":"1","key":"41268_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4274\/tjh.2018.0007","volume":"35","author":"MN Gamaletsou","year":"2018","unstructured":"Gamaletsou, M. N., Walsh, T. J. & Sipsas, N. V. Invasive fungal infections in patients with hematological malignancies: Emergence of resistant pathogens and new antifungal therapies. Turk. J. Haematol. 35(1), 1\u201311 (2018).","journal-title":"Turk. J. Haematol."},{"issue":"5","key":"41268_CR13","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/cid\/cir897","volume":"54","author":"F Lamoth","year":"2012","unstructured":"Lamoth, F. et al. \u03b2-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: A systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). Clin. Infect. Dis. 54(5), 633\u201343 (2012).","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"41268_CR14","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1080\/10717544.2020.1785050","volume":"27","author":"P Nimtrakul","year":"2020","unstructured":"Nimtrakul, P., Sermsappasuk, P. & Tiyaboonchai, W. Strategies to enhance oral delivery of amphotericin B: A comparison of uncoated and enteric-coated nanostructured lipid carriers. Drug Deliv. 27(1), 1054\u20131062 (2020).","journal-title":"Drug Deliv."},{"issue":"1","key":"41268_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00277-013-1867-1","volume":"93","author":"S Mousset","year":"2014","unstructured":"Mousset, S. et al. Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German society of hematology and oncology (DGHO). Ann. Hematol. 93(1), 13\u201332 (2014).","journal-title":"Ann. Hematol."},{"issue":"12","key":"41268_CR16","first-page":"3221","volume":"73","author":"JA Maertens","year":"2018","unstructured":"Maertens, J. A. et al. European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia. J. Antimicrob. Chemother. 73(12), 3221\u20133230 (2018).","journal-title":"J. Antimicrob. Chemother."},{"issue":"11","key":"41268_CR17","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/bmt.2015.181","volume":"50","author":"P Montesinos","year":"2015","unstructured":"Montesinos, P. et al. Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis. Bone Marrow Transplant. 50(11), 1465\u20131472 (2015).","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"41268_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/annonc\/mdu192","volume":"26","author":"G Maschmeyer","year":"2015","unstructured":"Maschmeyer, G. et al. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): Updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann. Oncol. 26(1), 21\u201333 (2015).","journal-title":"Ann. Oncol."},{"issue":"4","key":"41268_CR19","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw326","volume":"63","author":"TF Patterson","year":"2016","unstructured":"Patterson, T. F. et al. Practice guidelines for the diagnosis and management of Aspergillosis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 63(4), e1\u2013e60 (2016).","journal-title":"Clin Infect Dis."},{"issue":"10","key":"41268_CR20","first-page":"754","volume":"59","author":"Chinese Association Hematologists, Chinese Invasive Fungal Infection Working Group","year":"2020","unstructured":"Chinese Association Hematologists, Chinese Invasive Fungal Infection Working Group. The Chinese guidelines for the diagnosis and treatment of invasive fungal disease in patients with hematological disorders and cancers (the 6th revision). Zhonghua Nei Ke Za Zhi. 59(10), 754\u2013763 (2020).","journal-title":"Zhonghua Nei Ke Za Zhi."},{"issue":"12","key":"41268_CR21","doi-asserted-by":"publisher","first-page":"e893","DOI":"10.1016\/S2542-5196(21)00280-1","volume":"5","author":"AJ Browne","year":"2021","unstructured":"Browne, A. J. et al. Global antibiotic consumption and usage in humans, 2000\u201318: A spatial modelling study. Lancet Planet Health 5(12), e893\u2013e904 (2021).","journal-title":"Lancet Planet Health"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41268-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41268-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41268-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T03:14:17Z","timestamp":1700277257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41268-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,27]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["41268"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-41268-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,27]]},"assertion":[{"value":"29 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14008"}}